Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancer
about
Imiquimod - Its role in the treatment of cutaneous malignanciesNeutralizing tumor-promoting chronic inflammation: a magic bullet?The Yin and Yang of Toll-like receptors in cancerThe optimal partnership of radiation and immunotherapy: from preclinical studies to clinical translationClinical significance of tumor-infiltrating lymphocytes in breast cancerAGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2014.Toll-like receptor agonist imiquimod facilitates antigen-specific CD8+ T-cell accumulation in the genital tract leading to tumor control through IFNγCombinations of immunotherapy and radiation in cancer therapy.A novel systemically administered Toll-like receptor 7 agonist potentiates the effect of ionizing radiation in murine solid tumor modelsEfficacy of skin-directed therapy for cutaneous metastases from advanced cancer: a meta-analysis.The Immunomodulatory Small Molecule Imiquimod Induces Apoptosis in Devil Facial Tumour Cell LinesCurrent clinical trials testing combinations of immunotherapy and radiation.Synergy of topical toll-like receptor 7 agonist with radiation and low-dose cyclophosphamide in a mouse model of cutaneous breast cancerTumor-associated macrophages: unwitting accomplices in breast cancer malignancy.Is the skin a sanctuary for breast cancer cells during treatment with anti-HER2 antibodies?TLR agonists: our best frenemy in cancer immunotherapyA novel TLR7 agonist reverses NK cell anergy and cures RMA-S lymphoma-bearing miceToll-like receptors in prostate infection and cancer between bench and bedsidePromising Targets for Cancer Immunotherapy: TLRs, RLRs, and STING-Mediated Innate Immune PathwaysThe use of Toll-like receptor 7/8 agonists as vaccine adjuvants.Toll-like receptor agonists: a patent review (2011 - 2013).Modes of action of TLR7 agonists in cancer therapy.In situ vaccination: Cancer immunotherapy both personalized and off-the-shelf.In situ vaccination for the treatment of cancer.Biological Response Modifier in Cancer Immunotherapy.Intratumoral Delivery of Immunotherapy-Act Locally, Think Globally.Anti-tumor Activity of Toll-Like Receptor 7 Agonists.TLR7 agonist induced repression of hepatocellular carcinoma via the TLR7-IKK-NF-κB-IL6 signaling pathway.MAGE-specific T cells detected directly ex-vivo correlate with complete remission in metastatic breast cancer patients after sequential immune-endocrine therapy.The TLR7 agonist imiquimod as an adjuvant for radiotherapy-elicited in situ vaccination against breast cancer.Antigen Cross-Presentation and T-Cell Cross-Priming In Cancer Immunology And Immunotherapy.TLR Agonists as Adjuvants for Cancer Vaccines.Trial Watch: Toll-like receptor agonists for cancer therapy.Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.The TLR-specific adjuvants R-848 and CpG-B endorse the immunological reaction of neonatal antigen-presenting cells.Stimulating Innate Immunity to Enhance Radiation Therapy-Induced Tumor Control.Radiation and Anti-Cancer Vaccines: A Winning Combination.Novel combination strategies for enhancing efficacy of immune checkpoint inhibitors in the treatment of metastatic solid malignancies.Tumor Associated Macrophages as Therapeutic Targets for Breast Cancer.Harnessing the immune system in the battle against breast cancer.
P2860
Q26796536-6CB7104B-D050-4BA6-ACD6-711854FAEC14Q26830931-2B01B299-20CD-4F58-80A7-5FB2C3FE5F76Q26851526-D9EF70A3-3E7F-4329-B1B9-28AC3DAE0752Q27024106-5ADACCF4-F03F-4082-BAFC-B911ACC42107Q28070214-B07180BC-3980-4FDE-A7BB-629138F2D1B8Q34042627-7654C43D-0194-4F8D-AB36-007FD123A4E2Q34438411-6AFA7502-CC98-4459-BC4C-26E97AA228F6Q34582640-5F7A252E-5713-44EA-8B56-DB4CD52C723EQ34853959-925EC44B-A872-474F-9EEF-BE368B53240FQ35231246-29A4A6CB-B086-4BC6-BCA8-A76CB0812F28Q36218717-A02D866D-E780-4143-B082-3FC6E9CBAAD3Q36268306-09A79D01-0D2E-4EED-8B15-49FAEABF07EAQ36476394-3D5277ED-E5ED-4754-B6E8-089A6E4FADD3Q36692838-94BBCFD8-AA54-40D9-9E34-83717FFA10E1Q36843741-A6A7B0BA-FB59-4FEE-8520-011CD3E585D5Q36850457-D1B69D2E-3684-417D-BE0F-84D1F8723598Q37222176-75D8FA23-EB47-4F87-A259-DAFD6BCDA9D9Q37295411-07CE6219-A36E-44AF-8803-B46538BB013AQ37690959-FC6C251B-C331-4345-9FA4-0879DB5AAAE9Q38124064-D200AF47-818B-42EF-97E4-482553670E83Q38181176-8A64AAD3-3CAE-493B-AAA1-4269C4DF4EF0Q38271879-66881FAA-00F6-4EB5-80CE-BEFFF3F5EA49Q38657642-A18F56FB-F867-4C52-9855-0FE37C8F22BBQ38727470-90B3CDAB-69D7-4034-9A1B-6C5F21FD781AQ38848213-6D49F2D1-3894-4F43-943E-0FC17CDEBEB3Q39043844-C36CD8AB-8A67-43FE-B511-0CBFCE8F0B13Q39377049-F3D07588-D991-40D8-AC5C-28B2C8309503Q40485110-AE06DB77-62DE-4BA8-BC73-464A4AF3B3D7Q41510005-04408BCE-9510-44A7-8F57-2F2D073E492CQ41785872-F0EF8765-C1A8-4CE2-A66B-179C58FCA5BBQ41930681-2BCE26C5-5A81-4FB0-8361-7176260AC460Q41997055-E6EDA710-5ECC-4349-B35D-B6A263D7430EQ42969291-5DBF0DD3-578C-4963-90B5-6D076BFFF361Q43147493-9B4C5817-083D-440D-BB81-BD429472622AQ44546985-3C858263-1627-4420-859F-6984B7D3C1FBQ46189367-0E2935BD-9619-4967-80FF-BE6190B66B95Q47547584-912032E6-FC8D-4B9E-8987-D85FC472551CQ47936526-D2DC9D28-5CF6-4DCA-866B-C3329916F3A0Q49544289-D7257A83-2C44-4EC8-8FFB-5020FAECE185Q49884762-C4CB36DF-16BA-4501-B289-02579E6371D6
P2860
Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancer
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Topical TLR7 agonist imiquimod ...... in patients with breast cancer
@ast
Topical TLR7 agonist imiquimod ...... in patients with breast cancer
@en
type
label
Topical TLR7 agonist imiquimod ...... in patients with breast cancer
@ast
Topical TLR7 agonist imiquimod ...... in patients with breast cancer
@en
prefLabel
Topical TLR7 agonist imiquimod ...... in patients with breast cancer
@ast
Topical TLR7 agonist imiquimod ...... in patients with breast cancer
@en
P2093
P2860
P50
P1476
Topical TLR7 agonist imiquimod ...... in patients with breast cancer
@en
P2093
Amy Tiersten
Derya Unutmaz
Frank Martiniuk
James Speyer
Leonard Liebes
Lina Kozhaya
Nicholas Shuman
Nina Bhardwaj
Silvia C Formenti
Tsivia Hochman
P2860
P304
P356
10.1158/1078-0432.CCR-12-1149
P407
P577
2012-07-05T00:00:00Z